• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VALIANT STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VALIANT STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number UNK-CV-SR-VALIANT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Intimal Dissection (1333); Aneurysm (1708); Chest Pain (1776); Hematoma (1884); Neurological Deficit/Dysfunction (1982); Pain (1994); Rupture (2208)
Event Date 07/11/2020
Event Type  Injury  
Manufacturer Narrative
Medtronic received the following information obtained from the journal article entitled: outcomes of type a intramural hematoma: influence of diabetes mellitus chen et al, j card surg.2020; 35: 1811¿ 1821.Https://doi.Org/10.1111/jocs.14812.Sex: mean gender.Implant date: exact date of implant unknown.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Valiant stent grafts were implanted in conjunction with non mdt stent grafts in patients during tevar on unknown dates.The following adverse events were reported: type a aortic dissection, neurological complication, chest pain, back pain, hematoma thickening, ulcer-like projection and aortic aneurysm development and aortic rupture.The cause of the adverse events are undetermined.
 
Manufacturer Narrative
Additional information received: it was reported that none of the adverse events reported in the study were directly related to the valiant stent grafts.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALIANT STENT GRAFT
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
MDR Report Key10499235
MDR Text Key205884354
Report Number9612164-2020-03359
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P100040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK-CV-SR-VALIANT
Device Catalogue NumberUNK-CV-SR-VALIANT
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/17/2020
Initial Date FDA Received09/07/2020
Supplement Dates Manufacturer Received09/10/2020
Supplement Dates FDA Received10/08/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-